Refining immunosuppressive protocols in pediatric renal transplant recipients

This publication has 9 references indexed in Scilit:

• Efficacy and tolerability of interleukin‐2 receptor blockade with basiliximab in pediatric renal transplant recipients
  Pediatric Transplantation, 2001
• Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy.
  Pediatric Transplantation, 2001
• The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998
  Pediatric Transplantation, 2001
• Metabolism of Sirolimus and Its Derivative Everolimus by Cytochrome P450 3A4: Insights from Docking, Molecular Dynamics, and Quantum Chemical Calculations
  Journal of Medicinal Chemistry, 2001
• A RANDOMIZED, PROSPECTIVE, MULTICENTER TRIAL OF T-CELL ANTIBODY INDUCTION THERAPY IN PEDIATRIC RENAL TRANSPLANTATION.
  Transplantation, 2000
• Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?
  Pediatric Transplantation, 2000
• The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
  New England Journal of Medicine, 1998
• Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
  The Lancet, 1997
• Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action
  Therapeutic Drug Monitoring, 1995